INTERMED.CAP.GRP.LS-,2625INTERMED.CAP.GRP.LS-,2625INTERMED.CAP.GRP.LS-,2625

INTERMED.CAP.GRP.LS-,2625

No trades
See on Supercharts
Next report date
Report period
H2 2023
EPS estimate
0.74EUR
Revenue estimate
‪439.42 M‬EUR
Market capitalization
‪6.59 B‬EUR
‪319.30 M‬EUR
‪764.23 M‬EUR
‪282.10 M‬
Beta (1Y)
1.84

About INTERMEDIATE CAPITAL GROUP PLC ORD GBP0.2625

Sector
CEO
Benoît Laurent P. Durteste
Website
Headquarters
London
Employees (FY)
582
Founded
1988
FIGI
BBG000Q6Q1B4
Intermediate Capital Group Plc provides flexible capital solutions to help companies develop and grow. It is a global alternative asset manager with over 30 years' history, investing across the capital structure. It operates across four asset classes: Structured and Private Equity, Private Debt, Real Assets, and Credit. The company was founded by Andrew Jackson, Thomas Hugh Bartlam, Jean-Loup Brousse de Gersigny, James Odgers, Andrew Coventon Phillips, and Paul J. Piper on March 23, 1988 and is headquartered in London, the United Kingdom.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange INTERMED.CAP.GRP.LS-,2625 stocks are traded under the ticker I2X2.
INTERMED.CAP.GRP.LS-,2625 is going to release the next earnings report on May 28, 2024. Keep track of upcoming events with our Earnings Calendar.
I2X2 earnings for the last quarter are 0.75 EUR per share, whereas the estimation was 0.32 EUR resulting in a 132.79% surprise. The estimated earnings for the next quarter are 0.63 EUR per share. See more details about INTERMED.CAP.GRP.LS-,2625 earnings.
INTERMED.CAP.GRP.LS-,2625 revenue for the last quarter amounts to ‪468.49 M‬ EUR despite the estimated figure of ‪321.01 M‬ EUR. In the next quarter revenue is expected to reach ‪393.76 M‬ EUR.
Yes, you can track INTERMED.CAP.GRP.LS-,2625 financials in yearly and quarterly reports right on TradingView.
I2X2 net income for the last quarter is ‪259.61 M‬ EUR, while the quarter before that showed ‪281.30 M‬ EUR of net income which accounts for −7.71% change. Track more INTERMED.CAP.GRP.LS-,2625 financial stats to get the full picture.
INTERMED.CAP.GRP.LS-,2625 dividend yield was 6.37% in 2022, and payout ratio reached 78.89%. The year before the numbers were 4.26% and 41.37% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, I2X2 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade INTERMED.CAP.GRP.LS-,2625 stock right from TradingView charts — choose your broker and connect to your account.
I2X2 reached its all-time high on Nov 17, 2021 with the price of 28.2 EUR, and its all-time low was 6.0 EUR and was reached on Mar 19, 2020.
See other stocks reaching their highest and lowest prices.
As of Apr 27, 2024, the company has 582.00 employees. See our rating of the largest employees — is INTERMED.CAP.GRP.LS-,2625 on this list?
We've gathered analysts' opinions on INTERMED.CAP.GRP.LS-,2625 future price: according to them, I2X2 price has a max estimate of 30.27 EUR and a min estimate of 21.31 EUR. Read a more detailed INTERMED.CAP.GRP.LS-,2625 forecast: see what analysts think of INTERMED.CAP.GRP.LS-,2625 and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. INTERMED.CAP.GRP.LS-,2625 EBITDA is ‪644.64 M‬ EUR, and current EBITDA margin is 49.05%. See more stats in INTERMED.CAP.GRP.LS-,2625 financial statements.